Abstract:OBJECTIVE:To investigate the effects of survivin antisense oligodeoxynucleoties (ASODN) transfection mediated by cytofectin on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells in vitro. METHODS:A549/CDDP cells were cultured routinely in RPMI-1640 medium. Survivin ASODN mediated by cytofectin was transfected into the A549/CDDP cells. Reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry SABC assays were performed to determine the regulation of survivin expression by ASODN. The influence of ASODN transfection on apoptosis was determined by fluoroscence microscopy and Hoechst staining, agarose gel electrophoresis, flow cytometry and caspase-3 colorimetric assay. MTT assay was performed to detect the cell viability, half-maximum inhibitory concentration (IC50) and cisplatin resistance index (RI) were thereby calculated. RESULTS:Transfected by survivin ASODN for 48 h, down-regulation of survivin expression was measured, of which mRNA and protein expression was significantly down-regulated to 41.56% and 0.864 +/- 0.045, respectively (P < 0.05). Transfection with survivin ASODN caused typical apoptotic changes, including characteristic chromatin condensation, nuclear shrinkage, nuclear cleavage and the cells grew more regularly, and some cells were floating. Typical DNA ladder pattern was observed by agarose gel electrophoresis. Furthermore, apoptotic index and caspase-3 activity was enhanced to 34.03% and 1.1298 +/- 0.2502, respectively (P < 0.05). It was significantly different as compared with the control group. While combination with ASODN and 10 micromol/L cisplatin caused far more distinctive apoptotic alterations, of which AI and caspase-3 activity reached to 65.85% and 1.6805 +/- 0.2758, respectively (P < 0.05), and even compared with the single ASODN group, the difference was still significant (P < 0.05). Transfected with survivin ASODN only or with combination of cisplatin for 48 h, the inhibitory rate of cell growth was enhanced to 59.3% and 83.7% (P < 0.05), respectively, while inversely, the cell viability reduced to a lowest value. The half-maximum inhibitory concentration of cisplatin was reduced from 225.03 +/- 10.59 micromol/L to 158.84 +/- 4.26 micromol/L, and the resistant index was conversely reduced from 11.9 to 8.39. Non-sense oligodeoxynucleotides (NSODN) and liposome had no effect on the cells growth (P > 0.05). CONCLUSION:Transfection with survivin ASODN can to a great extent reverse the cisplatin resistance in human cisplatin resistant lung adenocarcinoma cells A549/CDDP in vitro, and can thereby significantly inhibit the growth of the cells. The mechanism of reversal of resistance to cisplatin by this transfection can be associated with specific down-regulation of survivin expression, which decreases the threshold of apoptosis, induces more pronounced apoptosis,and reverses the resistance to apoptosis induced by cisplatin in A549/CDDP cells in vitro.

Effects of Dihydroartemisinin on Apoptosis of the Human Lung Adenocarcinoma Cell Line A549/CDDP in Vitro

Apoptosis of HL-60 Cells Induced by Dihydroartemisinin

Effects of Dihydroartemisinin on the Proliferation and Apoptosis of Colon Carcinoma Cell Line SW480

Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation.

Effects Of Okadaic Acid Combined With Cisplatin On The Proliferation And Apoptosis Of Human Lung Adenocarcinoma A549 Cells

Dihydroartemisinin inhibits colon cancer cell viability by inducing apoptosis through up-regulation of PPARγ expression.

Dihydroartemisinin abolishes cisplatin-induced nephrotoxicity in vivo

Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy.

Dihydroartemisinin breaks the immunosuppressive tumor niche during cisplatin treatment in Hepatocellular carcinoma

[Dihydroartemisinin enhances sensitivity of nasopharyngeal carcinoma HNE1/DDP cells to cisplatin-induced apoptosis by promoting ROS production]

Dihydroartemisinin Treatment Exhibits Antitumor Effects in Glioma Cells Through Induction of Apoptosis

Dihydroartemisinin Increases Apoptosis of Colon Cancer Cells Through Targeting Janus Kinase 2/signal Transducer and Activator of Transcription 3 Signaling.

Potent Proapoptotic Actions of Dihydroartemisinin in Gemcitabine-Resistant A549 Cells.

Dihydroartemisinin Induces Apoptosis of Cervical Cancer Cells Via Upregulation of RKIP and Downregulation of Bcl-2.

Dihydroartemisinin induces radiosensitivity in cervical cancer cells by modulating cell cycle progression.

Dihydroartemisinin (DHA) Induces Caspase-3-dependent Apoptosis in Human Lung Adenocarcinoma ASTC-a-1 Cells

[Effect of Down-Regulation of Survivin Gene on Apoptosis and Cisplatin Resistance in Cisplatin Resistant Human Lung Adenocarcinoma A549/CDDP Cells].

Effects of artesunate on proliferation, apoptosis and chemotherapeutic drug sensitivity of human hepatocellular carcinoma HepG2 cells

Effect of curcumin on proliferation of human lung adenocarcinoma cell line A549/DDP

The effect of hyperthermia combined with cisplatin and docetaxel on human lung cancer cell line A549 in vitro

Effects of Dihydroartemisinin(DHA) regulation of squamous cell carcinoma A431 cells and Hacat cells proliferation and apoptosis